Journal Article10.1111/J.1464-5491.2011.03279.X
Lower extremity amputations — a review of global variability in incidence
Paul Moxey,P. Gogalniceanu,Robert J. Hinchliffe,Ian M. Loftus,K. J. Jones,Matt M. Thompson,Peter J. Holt +6 more
574
TL;DR: In this article, a literature review was performed using the EMBASE and MEDLINE databases from 1989 until 2010 for incidence of lower extremity amputation, showing significant variation with no single standard upon which to benchmark care.
read more
Abstract: Diabet. Med. 28, 1144–1153 (2011)
Abstract
Aim To quantify global variation in the incidence of lower extremity amputations in light of the rising prevalence of diabetes mellitus.
Methods An electronic search was performed using the EMBASE and MEDLINE databases from 1989 until 2010 for incidence of lower extremity amputation. The literature review conformed to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement standards.
Results Incidence of all forms of lower extremity amputation ranges from 46.1 to 9600 per 105 in the population with diabetes compared with 5.8–31 per 105 in the total population. Major amputation ranges from 5.6 to 600 per 105 in the population with diabetes and from 3.6 to 68.4 per 105 in the total population. Significant reductions in incidence of lower extremity amputation have been shown in specific at-risk populations after the introduction of specialist diabetic foot clinics.
Conclusion Significant global variation exists in the incidence of lower extremity amputation. Ethnicity and social deprivation play a significant role but it is the role of diabetes and its complications that is most profound. Lower extremity amputation reporting methods demonstrate significant variation with no single standard upon which to benchmark care. Effective standardized reporting methods of major, minor and at-risk populations are needed in order to quantify and monitor the growing multidisciplinary team effect on lower extremity amputation rates globally.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
What are the key conditions associated with lower limb amputations in a major Australian teaching hospital
Peter A Lazzarini,Peter A Lazzarini,Sharon R. O'Rourke,Anthony W. Russell,Anthony W. Russell,Damien Clark,Damien Clark,Suzanne Kuys,Suzanne Kuys +8 more
TL;DR: This study, the first in over 20 years to report on all levels of lower extremity amputations in Australia, found that people undergoing amputation are more likely to be older, male and have diabetes.
60
Step by Step: Finding Compensatory Order in Science
TL;DR: The authors argue that belief in science and progress can serve a similar function, and that perceiving order (regardless of external agency) can be sufficient to combat lack of control and that perceptions of order can be derived from science and from more general beliefs about progress.
EMG-driven control in lower limb prostheses: a topic-based systematic review
Andrea Cimolato,Josephus J. M. Driessen,Leonardo S. Mattos,Elena De Momi,Matteo Laffranchi,Lorenzo De Michieli +5 more
TL;DR: In this article , a comparative overview of EMG-driven control methods for lower limb prosthesis is presented, to identify their prospects and limitations, and to formulate suggestions on future research and development.
HbA1c and Lower Extremity Amputation Risk in Patients With Diabetes A Meta-Analysis
TL;DR: The meta-analysis indicates that high level of HbA1c is an important risk factor for LEA in patients with diabetes, and evidence supports the strategy for lowering glucose levels to reduce amputation in Patients with diabetes.
54
Editor's Choice – Trends in Lower Extremity Amputation Incidence in European Union 15+ Countries 1990–2017
Will Hughes,Richard Goodall,Justin D. Salciccioli,Dominic C Marshall,Alun H. Davies,Joseph Shalhoub +5 more
TL;DR: Variable trends in LEA incidence were observed across EU15+ countries, and do not reflect previously observed reductions in incidence of PAOD over the same time period.
52
References
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
TL;DR: Moher et al. as mentioned in this paper introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses, which is used in this paper.
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
TL;DR: A structured summary is provided including, as applicable, background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications of key findings.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher,Alessandro Liberati,Alessandro Liberati,Jennifer Tetzlaff,Douglas G. Altman test +4 more
TL;DR: PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) is introduced, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses.
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.
TL;DR: Since most patients with diabetes die from complications of atherosclerosis, they should receive intensive preventive interventions proven to reduce their cardiovascular risk.
2.9K
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.
Anne B. Newman,David S. Siscovick,Teri A. Manolio,Joseph F. Polak,Linda P. Fried,Nemat O. Borhani,Sidney K. Wolfson +6 more
TL;DR: There was an inverse dose-response relation of the AAI with CVD risk factors and subclinical and clinical CVD among older adults, and even those with modest, asymptomatic reductions in theAAI appear to be at increased risk of CVD.
1.2K